CD86 and COVID-19: We found that SARS-CoV-2-S+ exosomes of MILD COVID-19 patients were mostly of B cell, dendritic cell, and monocyte/macrophage origin, as they displayed B-cell marker CD19, integrin CD11b, costimulatory molecule CD86, and MHC-class II HLA-DR (Figure 3A).